new glp-1 drug retatrutide vs. Tirzepatide: The Next-Gen Showdown Retatrutide vs Semaglutide and Tirzepatide:
Description
It is not intended to replace professional medical advice, diagnosis, or treatment
LY3437943, a novel triple GIP, GLP-1, and glucagon receptor agonist in people with type 2 diabetes: a phase 1b, multicentre, double-blind, placebo-controlled, randomised, multiple-ascending dose trial
doi: 10.1055/a-2266-1503
J Clin Invest (2013) 123(6):27306
12 Semaglutide (Ozempic) modifies the natural glucagon-like peptide-1 molecule
